# The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health

> **NCT05259046** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Bispebjerg Hospital** · enrollment: 450 (actual)

## Conditions studied

- Coronary Artery Calcification
- Arterial Stiffness

## Interventions

- **DIETARY_SUPPLEMENT:** Menaquinone-7 (MK-7) tablet (333 µg)
- **DIETARY_SUPPLEMENT:** Placebo tablet

## Key facts

- **NCT ID:** NCT05259046
- **Lead sponsor:** Bispebjerg Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-21
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-02-28
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05259046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05259046, "The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05259046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*